-
1
-
-
0033006836
-
Cancer statistics, 1999
-
Landis SH, Murray T, Bolden S and Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 49(1): 8-31, 1999.
-
(1999)
CA Cancer J Clin
, vol.49
, Issue.1
, pp. 8-31
-
-
Landis, S.H.1
Murray, T.2
Bolden, S.3
Wingo, P.A.4
-
2
-
-
33645526144
-
Cancer statistics, Cancer statistics, 2006
-
Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, Cancer statistics, 2006. CA Cancer J Clin 56(2): 106-130, 2006.
-
(2006)
CA Cancer J Clin
, vol.56
, Issue.2
, pp. 106-130
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Murray, T.4
Xu, J.5
Smigal, C.6
Thun, M.J.7
-
4
-
-
21444447966
-
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower
-
Thompson IM, Ankerst DP, Chi C, Lucia MS, Goodman PJ, Crowley JJ, Parnes HL and Coltman CA Jr: Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. JAMA 294: 66-70, 2005.
-
(2005)
JAMA
, vol.294
, pp. 66-70
-
-
Thompson, I.M.1
Ankerst, D.P.2
Chi, C.3
Lucia, M.S.4
Goodman, P.J.5
Crowley, J.J.6
Parnes, H.L.7
Coltman Jr., C.A.8
-
5
-
-
4544254807
-
The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years?
-
Stamey TA, Caldwell M, McNeal JE, Nolley R, Hemenez M and Downs J: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol 172: 1297-1301, 2004.
-
(2004)
J Urol
, vol.172
, pp. 1297-1301
-
-
Stamey, T.A.1
Caldwell, M.2
McNeal, J.E.3
Nolley, R.4
Hemenez, M.5
Downs, J.6
-
6
-
-
0037305887
-
Prostate-specific antigen and human glandular kallikrein 2 in early detection of prostate cancer
-
Karazanashivili G and Abrahamsson PA: Prostate-specific antigen and human glandular kallikrein 2 in early detection of prostate cancer. J Urol 169: 445-457, 2003.
-
(2003)
J Urol
, vol.169
, pp. 445-457
-
-
Karazanashivili, G.1
Abrahamsson, P.A.2
-
7
-
-
3142527345
-
Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen
-
Punglia RS, D'amico AV, Catalona WJ, Roehl KA and Kuntz KM: Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med 46: 307-310, 2003.
-
(2003)
N Engl J Med
, vol.46
, pp. 307-310
-
-
Punglia, R.S.1
D'Amico, A.V.2
Catalona, W.J.3
Roehl, K.A.4
Kuntz, K.M.5
-
8
-
-
0033429470
-
DD3: A new prostate-specific gene, highly overexpressed in prostate cancer
-
Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N and Isaacs WB: DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 59: 5975-5979, 1999.
-
(1999)
Cancer Res
, vol.59
, pp. 5975-5979
-
-
Bussemakers, M.J.1
Van Bokhoven, A.2
Verhaegh, G.W.3
Smit, F.P.4
Karthaus, H.F.5
Schalken, J.A.6
Debruyne, F.M.7
Ru, N.8
Isaacs, W.B.9
-
9
-
-
0037974513
-
DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer
-
discussion 15-16
-
Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, Kiemeney LA, Witjes JA and Schalken JA: DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 44(1): 8-15; discussion 15-16, 2003.
-
(2003)
Eur Urol
, vol.44
, Issue.1
, pp. 8-15
-
-
Hessels, D.1
Klein Gunnewiek, J.M.2
Van Oort, I.3
Karthaus, H.F.4
Van Leenders, G.J.5
Van Balken, B.6
Kiemeney, L.A.7
Witjes, J.A.8
Schalken, J.A.9
-
10
-
-
0036569945
-
DD3(PCA3), a very sensitive and specific marker to detect prostate tumors
-
De Kok JB, Verhaegh GW, Roelofs RW, Hessels D, Kiemeney LA, Aalders TW, Swinkels DW and Schalken JA: DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res 62: 2695-2698, 2002.
-
(2002)
Cancer Res
, vol.62
, pp. 2695-2698
-
-
De Kok, J.B.1
Verhaegh, G.W.2
Roelofs, R.W.3
Hessels, D.4
Kiemeney, L.A.5
Aalders, T.W.6
Swinkels, D.W.7
Schalken, J.A.8
-
11
-
-
2342452144
-
uPM3, a new molecular urine test for the detection of prostate cancer
-
Fradet Y, Saad F, Aprikian A, Dessureault J, Elhilali M, Trudel C, Mâsse B, Piché L, Chypre C and Fradet Y: uPM3, a new molecular urine test for the detection of prostate cancer. Urology 64: 311-316, 2004.
-
(2004)
Urology
, vol.64
, pp. 311-316
-
-
Fradet, Y.1
Saad, F.2
Aprikian, A.3
Dessureault, J.4
Elhilali, M.5
Trudel, C.6
Mâsse, B.7
Piché, L.8
Chypre, C.9
Fradet, Y.10
-
12
-
-
3142540904
-
DD3/PCA3 RNA analysis in urine a new perspective for detecting prostate cancer
-
Tinzl M, Marberger M and Horvath S: DD3/PCA3 RNA analysis in urine a new perspective for detecting prostate cancer. Eur Urol 46: 182-187, 2004.
-
(2004)
Eur Urol
, vol.46
, pp. 182-187
-
-
Tinzl, M.1
Marberger, M.2
Horvath, S.3
-
13
-
-
33646942410
-
APTIMA PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer
-
Groskopf J, Auhin SMJ and Deras IL: APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clin Chem 52: 1089-1095, 2006.
-
(2006)
Clin Chem
, vol.52
, pp. 1089-1095
-
-
Groskopf, J.1
Auhin, S.M.J.2
Deras, I.L.3
-
14
-
-
33644849700
-
The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia
-
Marangoni K, Neves AF, Cardoso AM, Santos WK, Faria PC and Goulart LR: The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia. Cancer Detect Prev 30: 7-13, 2006.
-
(2006)
Cancer Detect Prev
, vol.30
, pp. 7-13
-
-
Marangoni, K.1
Neves, A.F.2
Cardoso, A.M.3
Santos, W.K.4
Faria, P.C.5
Goulart, L.R.6
-
15
-
-
21344471138
-
Real-time RT-PCR normalisation; strategics and considerations
-
Huggett J, Dheda K, Bustin S and Zumla A: Real-time RT-PCR normalisation; strategics and considerations. Genes Immun 6: 279-284, 2005.
-
(2005)
Genes Immun
, vol.6
, pp. 279-284
-
-
Huggett, J.1
Dheda, K.2
Bustin, S.3
Zumla, A.4
-
16
-
-
0032855594
-
Prostate-specific antigen: A decade of discovery what we have learned and where we are going
-
Polascik TJ, Oesterling JE and Partin AW: Prostate-specific antigen: a decade of discovery what we have learned and where we are going. J Urol 162(2): 293-306, 1999.
-
(1999)
J Urol
, vol.162
, Issue.2
, pp. 293-306
-
-
Polascik, T.J.1
Oesterling, J.E.2
Partin, A.W.3
-
17
-
-
8444251062
-
Prostate-specific antigen (PSA) best practice policy
-
Thompson IM, Carroll P and Coley C: Prostate-specific antigen (PSA) best practice policy. Oncology 14: 267-286, 2000.
-
(2000)
Oncology
, vol.14
, pp. 267-286
-
-
Thompson, I.M.1
Carroll, P.2
Coley, C.3
-
18
-
-
33644658639
-
Predictive probability of serum prostate-specific antigen for prostate cancer: An approach using Bayes rule
-
Vollmer RT: Predictive probability of serum prostate-specific antigen for prostate cancer: an approach using Bayes rule. Am J Clin Pathol 125: 336-342, 2006.
-
(2006)
Am J Clin Pathol
, vol.125
, pp. 336-342
-
-
Vollmer, R.T.1
-
19
-
-
0036090461
-
Serial biopsy results in prostate cancer screening study
-
Roehl KA, Antenor JA and Catalona WJ: Serial biopsy results in prostate cancer screening study. J Urol 167: 2435-2439, 2002.
-
(2002)
J Urol
, vol.167
, pp. 2435-2439
-
-
Roehl, K.A.1
Antenor, J.A.2
Catalona, W.J.3
-
20
-
-
0032836721
-
Molecular detection of prostate cells in ejaculate and urethral washings of men with suspected prostate cancer
-
Clements JA, Rhode P, Allen V, Hyland VJ, Samaratunga ML and Tillev WD: Molecular detection of prostate cells in ejaculate and urethral washings of men with suspected prostate cancer. J Urol 167: 1337-1342, 1999.
-
(1999)
J Urol
, vol.167
, pp. 1337-1342
-
-
Clements, J.A.1
Rhode, P.2
Allen, V.3
Hyland, V.J.4
Samaratunga, M.L.5
Tillev, W.D.6
-
21
-
-
0038509093
-
Molecular diagnostics in urologic oncology. Detection of nucleic acids in urine samples
-
Muller M, Goessl C, Krause H and Miller K: Molecular diagnostics in urologic oncology. Detection of nucleic acids in urine samples. Urologe A 42: 660-668, 2003.
-
(2003)
Urologe A
, vol.42
, pp. 660-668
-
-
Muller, M.1
Goessl, C.2
Krause, H.3
Miller, K.4
-
22
-
-
0034872916
-
DNA-based detection of prostate cancer in urine after prostatic massage
-
Goessl C, Muller M, Heicappell R, Krause H, Straub B and Schrader M: DNA-based detection of prostate cancer in urine after prostatic massage. Urology 58: 335-338, 2001.
-
(2001)
Urology
, vol.58
, pp. 335-338
-
-
Goessl, C.1
Muller, M.2
Heicappell, R.3
Krause, H.4
Straub, B.5
Schrader, M.6
-
23
-
-
0034808413
-
Molecular detection of prostate cancer in urine by GSTP1 hypermethylation
-
Cairns P, Esteller M, Hermann JG, Schoenberg M, Jeronimo C and Sanchez-Cespedes M: Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin Cancer Res 7: 2727-2730, 2001.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 2727-2730
-
-
Cairns, P.1
Esteller, M.2
Hermann, J.G.3
Schoenberg, M.4
Jeronimo, C.5
Sanchez-Cespedes, M.6
-
24
-
-
0035050869
-
Dual-label detection of amplified products in quantitative RT-PCR assay using lanthanide-labeled probes
-
Ylikoski A, Karp M, Lilja H and Lovgren T: Dual-label detection of amplified products in quantitative RT-PCR assay using lanthanide-labeled probes. Biotechniques 30(4): 832-836, 2001.
-
(2001)
Biotechniques
, vol.30
, Issue.4
, pp. 832-836
-
-
Ylikoski, A.1
Karp, M.2
Lilja, H.3
Lovgren, T.4
-
25
-
-
43949143180
-
Biomarkers for early prostate cancer detection
-
Margreiter M, Stangelberger A, Valimberti E, Herwig R and Djavan B: Biomarkers for early prostate cancer detection. Minerva Urol Nefrol 60(1): 51-60, 2008.
-
(2008)
Minerva Urol Nefrol
, vol.60
, Issue.1
, pp. 51-60
-
-
Margreiter, M.1
Stangelberger, A.2
Valimberti, E.3
Herwig, R.4
Djavan, B.5
-
26
-
-
43549084349
-
New circulating biomarkers for prostate cancer
-
Bensalah K, Lotan Y, Karam JA and Shariat SF: New circulating biomarkers for prostate cancer. Prostate Cancer Prostatic Dis 11(2): 112-120, 2008.
-
(2008)
Prostate Cancer Prostatic Dis
, vol.11
, Issue.2
, pp. 112-120
-
-
Bensalah, K.1
Lotan, Y.2
Karam, J.A.3
Shariat, S.F.4
-
27
-
-
57149118933
-
Emerging biomarkers for the diagnosis and prognosis of prostate cancer
-
Sardana G, Dowell B and Diamandis EP: Emerging biomarkers for the diagnosis and prognosis of prostate cancer. Clin Chem 54(12): 1951-1960, 2008.
-
(2008)
Clin Chem
, vol.54
, Issue.12
, pp. 1951-1960
-
-
Sardana, G.1
Dowell, B.2
Diamandis, E.P.3
-
28
-
-
34249941898
-
Quantitative detection of DD3 mRNA in prostate cancer tissues by real-time fluorescent quantitative reverse transcription polymerase chain reaction
-
Tao ZH, Mao XL, Wang CH, Chen XD, Yu KY, Weng ZL, Hu YP, Zhang XH, Xie H, Wang OC, Song QT, Li CD and Chen ZG: Quantitative detection of DD3 mRNA in prostate cancer tissues by real-time fluorescent quantitative reverse transcription polymerase chain reaction. Zhonghua Nan Ke Xue 13(2): 130-133, 2007.
-
(2007)
Zhonghua Nan Ke Xue
, vol.13
, Issue.2
, pp. 130-133
-
-
Tao, Z.H.1
Mao, X.L.2
Wang, C.H.3
Chen, X.D.4
Yu, K.Y.5
Weng, Z.L.6
Hu, Y.P.7
Zhang, X.H.8
Xie, H.9
Wang, O.C.10
Song, Q.T.11
Li, C.D.12
Chen, Z.G.13
-
29
-
-
0033775615
-
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
-
Bustin SA: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25(2): 169-193, 2000.
-
(2000)
J Mol Endocrinol
, vol.25
, Issue.2
, pp. 169-193
-
-
Bustin, S.A.1
-
30
-
-
23944492941
-
Canadian guidelines for the management of benign prostatic hyperplasia
-
Canadian Prostate Health Council; Canadian Urological Association Guidelines Committee.
-
Nickel JC, Herschorn S, Corcos J, Donnelly B, Drover D, Elhilali M, Goldenberg L, Grantmyre J, Laroche B, Norman R, Piercy B, Psooy K, Steinhoff G, Trachtenberg J, Saad F and Tanguay S: Canadian Prostate Health Council; Canadian Urological Association Guidelines Committee. Canadian guidelines for the management of benign prostatic hyperplasia. Can J Urol 12(3): 2677-2683, 2005.
-
(2005)
Can J Urol
, vol.12
, Issue.3
, pp. 2677-2683
-
-
Nickel, J.C.1
Herschorn, S.2
Corcos, J.3
Donnelly, B.4
Drover, D.5
Elhilali, M.6
Goldenberg, L.7
Grantmyre, J.8
Laroche, B.9
Norman, R.10
Piercy, B.11
Psooy, K.12
Steinhoff, G.13
Trachtenberg, J.14
Saad, F.15
Tanguay, S.16
-
31
-
-
33645886619
-
Correlation between serum prostate-specific antigen and alpha-1-antitrypsin in men without and with prostate cancer
-
Kuvibidila S and Rayford W: Correlation between serum prostate-specific antigen and alpha-1-antitrypsin in men without and with prostate cancer. J Lab Clin Med 147(4): 174-181, 2006.
-
(2006)
J Lab Clin Med
, vol.147
, Issue.4
, pp. 174-181
-
-
Kuvibidila, S.1
Rayford, W.2
-
32
-
-
24644519463
-
European Association of Urology: EAU guidelines on prostate cancer
-
Aus G, Abbou CC, Bolla M, Heidenreich A, Schmid HP, van Poppel H, Wolff J and Zattoni F: European Association of Urology: EAU guidelines on prostate cancer. Eur Urol 48(4): 546-551, 2005.
-
(2005)
Eur Urol
, vol.48
, Issue.4
, pp. 546-551
-
-
Aus, G.1
Abbou, C.C.2
Bolla, M.3
Heidenreich, A.4
Schmid, H.P.5
Van Poppel, H.6
Wolff, J.7
Zattoni, F.8
-
33
-
-
67650874081
-
Cancer statistics, 2009
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59(4): 225-249, 2009.
-
(2009)
CA Cancer J Clin
, vol.59
, Issue.4
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
34
-
-
51349160629
-
Prostate-specific antigen (PSA)-based screening
-
American Urological Association
-
Suzuki H, Flanigan RC and Okuyama A; American Urological Association: Prostate-specific antigen (PSA)-based screening. Int J Urol 15(9): 757-762, 2008.
-
(2008)
Int J Urol
, vol.15
, Issue.9
, pp. 757-762
-
-
Suzuki, H.1
Flanigan, R.C.2
Okuyama, A.3
|